ASP Isotopes Inc.
CIK: 0001921865
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NDRA
ENDRA Life Sciences Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About ASP Isotopes Inc.
ASP Isotopes Inc. (SEC CIK 0001921865) files insider reports with the SEC as 10% Owner of ENDRA Life Sciences Inc. (NDRA).
Signal8 holds 1 ownership filing by ASP Isotopes Inc., a Form 3, filed on Oct 8, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on ASP Isotopes Inc.'s filings is in DALLAS, TX.
Other insiders filing for ENDRA Life Sciences Inc. (NDRA)
- Tokman Alexander Y, Chief Executive Officer
- Jacroux Richard, Chief Financial Officer
- DIGIANDOMENICO ANTHONY, Director
- Harsh Michael, Director
- Basenese Lou, Director
- UBS Group AG, Officer